Health Watchdogs Sound Alarm Over TB/HIV Deaths
July 27, 2010
The scourge of co-infection with HIV and TB is the target of a health care initiative launched at the 18th International AIDS Conference in Vienna.
While acknowledging that reaching the goal would require billions of dollars annually, conference speakers focused on low-cost strategies that have been shown to cut HIV/TB mortality. "There is a package of activities that, if properly implemented by countries, will work," said Stop TB Executive Secretary Marcos Espinal.
Health care facilities and laboratories should be designed to handle both HIV and TB. To help identify and treat TB as early as possible, health care workers should ask HIV-positive patients whether they have had any recent coughing episodes.
In addition, French and U.S. researchers reported trial results that suggest changes in the typical treatment schedule for patients co-infected with HIV and TB.
In a Cambodian trial of seriously ill HIV patients newly infected with TB, researchers compared the standard approach, starting TB treatment and then waiting eight weeks to initiate antiretroviral therapy (ART), with an experimental approach of waiting only two weeks to introduce HIV treatment. The team recorded 59 deaths among the 332 patients who started ART at two weeks, compared to 90 deaths among the 329 patients who started ART at eight weeks (death rates of 18 percent and 27 percent, respectively).
Agence France Presse
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)